Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force

Averna, Maurizio; Banach, Maciej; Bruckert, Eric; Drexel, Heinz; Farnier, Michel; Gaita, Dan; Magni, Paolo; Maerz, Winfried; Masana, Luis; Mello e Silva, Alberto; Reiner, Zeljko; Ros, Emilio; Vrablik, Michal; Zambon, Alberto; Zamorano, Jose; Stock, Jane; Tokgozoglu, Lale; Catapano, Alberico

doi:10.1016/j.atherosclerosis.2021.03.039

Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force

Copy For Citation

Averna M., Banach M., Bruckert E., Drexel H., Farnier M., Gaita D., ...More

ATHEROSCLEROSIS, vol.325, pp.99-109, 2021 (SCI-Expanded)

Publication Type: Article / Article
Volume: 325
Publication Date: 2021
Doi Number: 10.1016/j.atherosclerosis.2021.03.039
Journal Name: ATHEROSCLEROSIS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, Chemical Abstracts Core, EMBASE, Food Science & Technology Abstracts, MEDLINE, Veterinary Science Database
Page Numbers: pp.99-109
Hacettepe University Affiliated: Yes

Abstract

Background and aims: This European Atherosclerosis Society (EAS) Task Force provides practical guidance for combination therapy for elevated low-density lipoprotein cholesterol (LDL-C) and/or triglycerides (TG) in highrisk and very-high-risk patients.